Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts

Molecular and Cellular Biology

Volumn 15, Issue 9, 1995, Pages 4745-4753

  Rogan, Eileen M ^a   Bryan, Tracy M ^a   Hukku, Bharati ^c   Maclean, Kenneth ^a   Chang, Andy C M ^a   Moy, Elsa L ^a   Englezou, Anna ^a   Warneford, Sally G ^a   Dalla Pozza, Luciano ^b   Reddel, Roger R ^a  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CELL VIABILITY; FAMILIAL CANCER; FIBROBLAST; HUMAN; MUTANT; PRIORITY JOURNAL; TELOMERE; ANIMAL; CARCINOGEN TESTING; CASE REPORT; CELL AGING; CELL CULTURE; CHROMOSOME ABERRATION; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; GENETICS; HETEROZYGOTE; KARYOTYPING; METABOLISM; MOLECULAR GENETICS; MOUSE; MUTATION; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PLOIDY;

CARRIER PROTEIN; DNA NUCLEOTIDYLEXOTRANSFERASE; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL; BASE SEQUENCE; CARCINOGENICITY TESTS; CARRIER PROTEINS; CASE REPORT; CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHROMOSOME ABERRATIONS; DNA NUCLEOTIDYLEXOTRANSFERASE; FIBROBLASTS; HETEROZYGOTE; KARYOTYPING; LI-FRAUMENI SYNDROME; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, EXPERIMENTAL; PLOIDIES; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; SUPPORT, NON-U.S. GOV'T; TELOMERE;

EID: 0028981380     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.15.9.4745     Document Type: Article

References (58)

1. Allsopp, R. C., H. Vaziri, C. Patterson, S. Goldstein, E. V. Younglai, A. B. Futcher, C. W. Greider, and C. B. Harley. 1992. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 89: 10114-10118.
2. Bartek, J., J. Bartkova, N. Kyprianou, E.-N. Lalani, Z. Staskova, M. Shearer, S. Chang, and J. Taylor-Papadimitriou. 1991. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc. Natl. Acad. Sci. USA 88:3520-3524.
3. Bischoff, F. Z., S. O. Yim, S. Pathak, G. Grant, M. Siciliano, B. C. Giovanella, L. C. Strong, and M. A. Tainsky. 1990. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res. 50:7979-7984.
4. Bond, J. A., F. S. Wyllie, and D. Wynford-Thomas. 1994. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9:1885-1889.
5. Bryan, T. M., A. Englezou, and R. R. Reddel. Unpublished data.
6. Bryan, T. M., and R. R. Reddel. 1994. SV40-induced immortalization of human cells. Crit. Rev. Oncog. 5:331-357.
7. Carder, P., A. H. Wyllie, C. A. Purdie, R. G. Morris, S. White, J. Piris, and C. C. Bird. 1993. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 8:1397-1401.
8. Counter, C. M., A. A. Avilion, C. E. LeFeuvre, N. G. Stewart, C. W. Greider, C. B. Harley, and S. Bacchetti. 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1921-1929.
9. Counter, C. M., F. M. Botelho, P. Wang, C. B. Harley, and S. Bacchetti. 1994. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J. Virol. 68:3410-3414.
10. Counter, C. M., H. W. Hirte, S. Bacchetti, and C. B. Harley. 1994. Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA 91-2900-2904.
11. De Silva, R., N. J. Whitaker, E. M. Rogan, and R. R. Reddel. 1994. Human papillomavirus type 16 E6 and E7 genes, like simian virus 40 early region genes, are insufficient for immortalization of human mesothelial and bronchial epithelial cells. Exp. Cell Res. 213:418-427.
12. Duncan, E. L., N. J. Whitaker, E. L. Moy, and R. R. Reddel. 1993. Assignment of SV40-immortalized cells to more than one complementation group for immortalization. Exp. Cell Res. 205:337-344.
13. Dyson, N., K. Buchkovich, P. Whyte, and E. Harlow. 1989. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58:249-255.
14. Girardi, A. J., F. C. Jensen, and H. Koprowski. 1965. SV40-induced transformation of human diploid cells: crisis and recovery. J. Cell. Comp. Physiol. 65:69-84.
15. Hannon, G. J., D. Demetrick, and D. Beach. 1993. Isolation of the RB-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7:2378-2391.
16. Hara, E., H. Tsurui, A. Shinozaki, S. Nakada, and K. Oda. 1991. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179:528-534.
17. Harley, C. B. 1991. Telomere loss: mitotic clock or genetic time bomb? Mutat Res. DNAging Genet. Instability Aging 256:271-282.
18. Harley, C. B., A. B. Futcher, and C. W. Greider. 1990. Telomeres shorten during aging of human fibroblasts. Nature (London) 345:458-460.
19. Harley, C. B., H. Vaziri, C. M. Counter, and R. C. Allsopp. 1992. The telomere hypothesis of cellular aging. Exp. Gerontol. 27:375-382.
20. Hastie, N. D., M. Dempster, M. G. Dunlop, A. M. Thompson, D. K. Green, and R. C. Allshire. 1990. Telomere reduction in human colorectal carcinoma and with ageing. Nature (London) 346:866-868.
21. Hayflick, L., and P. S. Moorhead. 1961. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25:585-621.
22. Holzman, K., N. Blin, C. Welter, K. D. Zang, G. Seitz, and W. Henn. 1993. Telomeric associations and loss of telomeric DNA repeats in renal tumors. Genes Chromosomes Cancer 6:178-181.
23. Kaighn, M. E., R. R. Reddel, J. F. Lechner, D. M. Peehl, R. F. Camalier, D. E. Brash, U. Saffiotti, and C. C. Harris. 1989. Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. Cancer Res. 49:3050-3056.
24. Kamb, A., N. A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V. Tavtigian, E. Stockert, R. S. Day, B. E. Johnson, and M. H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
25. Kim, N. W., M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. C. Ho, G. M. Coviello, W. A. Wright, S. L. Weinrich, and J. W. Shay. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
26. Klingelhutz, A. J., S. A. Barber, P. P. Smith, K. Dyer, and J. K. McDougall. 1994. Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol. Cell. Biol. 14:961-969.
27. Lehman, T. A., W. P. Bennett, R. A. Metcalf, J. A. Welsh, J. Ecker, R. V. Modali, S. Ullrich, J. W. Romano, E. Appella, J. R. Testa, B. I. Gerwin, and C. C. Harris. 1991. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res. 51:4090-4096
28. Levis, R. W., R. Ganesan, K. Houtchens, L. A. Tolar, and F. Sheen. 1993. Transposons in place of telomeric repeats at a Drosophila telomere. Cell 75:1083-1093.
29. Levy, M. Z., R. C. Allsopp, A. B. Futcher, C. W. Greider, and C. B. Harley. 1992. Telomere end-replication problem and cell aging. J. Mol. Biol. 225: 951-960.
30. Li, F. P., and J. F. Fraumeni. 1969. Soft tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome. Ann. Intern. Med. 71:747-752.
31. Li, F. P., and J. F. Fraumeni. 1982. Prospective study of a cancer family syndrome. JAMA 247:2692-2694.
32. Livingstone, L. R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T. D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
33. Lundblad, V., and E. H. Blackburn. 1993. An alternative pathway for yeast telomere maintenance rescues est1- senescence. Cell 73:347-360.
34. Maclean, K., E. M. Rogan, N. J. Whitaker, A. C.-M. Chang, P. B. Rowe, L. Dalla-Pozza, G. Symonds, and R. R. Reddel. 1994. In vitro transformation of Li-Fraumeni syndrome fibroblasts with SV40 large T antigen mutants. Oncogene 9:719-725.
35. Malkin, D., F. P. Li, L. C. Strong, J. F. Fraumeni, C. E. Nelson, D. H. Kim, J. Kassel, M. A. Gryka, F. Z. Bischoff, M. A. Tainsky, and S. H. Friend. 1990. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250:1233-1238.
36. Mann, G. Personal communication.
37. Morin, G. B. 1989. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59:521-529.
38. Murnane, J. P., L. Sabatier, B. A. Marder, and W. F. Morgan. 1994. Telomere dynamics in an immortal human cell line. EMBO J. 13:4953-4962.
39. Nilsson, P., C. Mehle, K. Remes, and G. Roos. 1994. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 9:3043-3048.
40. Nobori, T., K. Miura, D. J. Wu, A. Lois, K. Takabayashi, and D. A. Carson. 1994. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (London) 368:753-756.
41. INK4 in human cancer. Proc. Natl. Acad. Sci. USA 91:11045-11049.
42. Olovnikov, A. M. 1973. A theory of marginotomy. J. Theor. Biol. 41:181-190.
43. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9:3375-3378.
44. Peterson, W. D., W. F. Simpson, and B. Hukku. 1979. Cell culture characterization: monitoring for cell identification. Methods Enzymol. 58:164-178.
45. Reddel, R. R., Y. Ke, B. I. Gerwin, M. G. McMenamin, J. F. Lechner, R. T. Su, D. E. Brash, J. B. Park, J. S. Rhim, and C. C. Harris. 1988. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48:1904-1909.
46. Rogan, E. M., K. Maclean, E. L. Moy, and R. R. Reddel. Unpublished results.
47. Sack, G. H., and C. Obie. 1981. Human cell transformation by simian virus 40. Exp. Cell Res. 134:425-432.
48. Saltman, D., R. Morgan, M. L. Cleary, and T. de Lange. 1993. Telomeric structure in cells with chromosome end associations. Chromosoma 102:121-128.
49. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
50. Seabright, M. 1971. A rapid banding technique for human chromosomes. Lancet ii:971-972.
51. Shay, J. W., G. Tomlinson, M. A. Piatyszek, and L. S. Gollahon. 1995. Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol. Cell. Biol. 15:425-432.
52. Shay, J. W., W. E. Wright, D. Brasiskyte, and B. A. Van Der Haegen. 1993. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene 8:1407-1413.
53. Srivastava, S., Z. Zhou, K. Pirollo, W. Blattner, and E. H. Chang. 1990. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature (London) 348:747-749.
54. Tsukada, T., Y. Tomooka, S. Takai, Y. Ueda, S. Nishikawa, T. Yagi, T. Tokunaga, N. Takeda, Y. Suda, S. Abe, I. Matsuo, Y. Ikawa, and S. Aizawa. 1993. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8:3313-3322.
55. Wang, S.-S., and V. A. Zakian. 1990. Telomere-telomere recombination provides an express pathway for telomere acquisition. Nature (London) 345:456-458.
56. Warneford, S. G., L. J. Witton, M. Townsend, R. R. Reddel, L. Dalla-Pozza, and G. Symonds. 1992. Germ-line splicing mutation of the p53 gene in a cancer-prone family. Cell Growth Differ. 3:839-846.
57. Xu, H.-J., S.-X. Hu, T. Hashimoto, R. Takahashi, and W. F. Benedict. 1989. The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. Oncogene 4:807-812.
58. Yin, Y., M. A. Tainsky, F. Z. Bischoff, L. C. Strong, and G. M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948.